{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:19:16Z","timestamp":1789604356626,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ejso.2020.06.040","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T11:51:47Z","timestamp":1594641107000},"page":"2140-2146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Factors predicting toxicity and response following isolated limb infusion for melanoma: An international multi-centre study"],"prefix":"10.1016","volume":"46","author":[{"given":"Timothy J.","family":"Kenyon-Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8923-7527","authenticated-orcid":false,"given":"Hidde M.","family":"Kroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcri","family":"Teras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia M.","family":"Beasley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma E.","family":"Farrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara R.","family":"Farley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishwarya","family":"Potdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Daou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Farma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Speakman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Serpell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Delman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Mark","family":"Smithers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Barbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon J.","family":"Coventry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Tyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Zager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2020.06.040_bib1","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2020.06.040_bib2","doi-asserted-by":"crossref","first-page":"e528","DOI":"10.14694\/EdBook_AM.2015.35.e528","article-title":"Perfusion and infusion for melanoma in-transit metastases in the era of effective systemic therapy","author":"Grunhagen","year":"2015","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ejso.2020.06.040_bib3","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ejso.2016.10.005","article-title":"Diagnosis and treatment of in-transit melanoma metastases","volume":"43","author":"Testori","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.06.040_bib4","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJMoa1802357","article-title":"Adjuvant pembrolizumab versus placebo in resected stage III melanoma","volume":"378","author":"Eggermont","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2020.06.040_bib5","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1245\/s10434-019-07288-w","article-title":"Long-term oncologic outcomes after isolated limb infusion for locoregionally metastatic melanoma: an international multicenter analysis","volume":"26","author":"Miura","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.06.040_bib6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1067\/j.cpsurg.2011.02.002","article-title":"Isolated limb perfusion and isolated limb infusion for malignant lesions of the extremities","volume":"48","author":"Sanki","year":"2011","journal-title":"Curr Probl Surg"},{"key":"10.1016\/j.ejso.2020.06.040_bib7","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/jso.23553","article-title":"Isolated limb infusion with melphalan and actinomycin-D for melanoma: a systematic review","volume":"109","author":"Kroon","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2020.06.040_bib8","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1245\/s10434-017-6046-5","article-title":"Safety and efficacy of isolated limb infusion chemotherapy for advanced locoregional melanoma in elderly patients: an Australian multicenter study","volume":"24","author":"Kroon","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.06.040_bib9","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jamcollsurg.2008.12.019","article-title":"A\u00a0multi-institutional experience of isolated limb infusion: defining response and toxicity in the US","volume":"208","author":"Beasley","year":"2009","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.ejso.2020.06.040_bib10","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/jso.23540","article-title":"Isolated limb infusion: technical aspects","volume":"109","author":"Kroon","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2020.06.040_bib11","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1245\/s10434-008-9988-9","article-title":"Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion","volume":"15","author":"Beasley","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.06.040_bib12","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0277-5379(82)90235-8","article-title":"Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions","volume":"18","author":"Wieberdink","year":"1982","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejso.2020.06.040_bib13","series-title":"Handbook for reporting results of cancer treatment","author":"Hunter","year":"1979"},{"key":"10.1016\/j.ejso.2020.06.040_bib14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejso.2020.06.040_bib15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1245\/s10434-014-4072-0","article-title":"Burden of disease predicts response to isolated limb infusion with melphalan and actinomycin D in melanoma","volume":"22","author":"Muilenburg","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.06.040_bib16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/cpt.644","article-title":"Associations of high-dose melphalan pharmacokinetics and outcomes in the setting of a randomized cryotherapy trial","volume":"102","author":"Cho","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ejso.2020.06.040_bib17","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1245\/s10434-009-0323-x","article-title":"Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin D in melanoma patients","volume":"16","author":"Kroon","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.06.040_bib18","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1161\/01.CIR.81.5.1498","article-title":"Body fat distribution and male\/female differences in lipids and lipoproteins","volume":"81","author":"Freedman","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.ejso.2020.06.040_bib19","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1245\/s10434-008-0288-1","article-title":"Optimizing melphalan pharmacokinetics in regional melanoma therapy: does correcting for ideal body weight alter regional response or toxicity?","volume":"16","author":"McMahon","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.06.040_bib20","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ejso.2019.02.026","article-title":"Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: an Australian multi-center study","volume":"45","author":"Kroon","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.06.040_bib21","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1245\/s10434-009-0563-9","article-title":"Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional analysis","volume":"16","author":"Santillan","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.06.040_bib22","series-title":"In: Balch CM, Thompson JF et\u00a0al, Cutaneous Melanoma 6th edition","first-page":"827","article-title":"Isolated limb infusion for melanoma","author":"Beasley","year":"2020"},{"key":"10.1016\/j.ejso.2020.06.040_bib23","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1245\/s10434-011-1646-y","article-title":"Does increased experience with isolated limb infusion for advanced melanoma influence outcome? A comparison of two treatment periods at a single institution","volume":"18","author":"Huismans","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.06.040_bib24","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.amjsurg.2003.07.019","article-title":"Marked variability of melphalan plasma drug levels during regional hyperthermic isolated limb perfusion","volume":"186","author":"Cheng","year":"2003","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejso.2020.06.040_bib25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00008390-200108000-00014","article-title":"Pharmacokinetics and pharmacodynamics of melphalan in isolated limb infusion for recurrent localized limb malignancy","volume":"11","author":"Roberts","year":"2001","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejso.2020.06.040_bib26","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1002\/cncr.27676","article-title":"A\u00a0multi-institution experience comparing the clinical and physiologic differences between upper extremity and lower extremity melphalan-based isolated limb infusion","volume":"118","author":"Beasley","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2020.06.040_bib27","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.4161\/cc.8.17.9503","article-title":"Specific activation of the p53 pathway by low dose actinomycin D: a new route to p53 based cyclotherapy","volume":"8","author":"Choong","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejso.2020.06.040_bib28","doi-asserted-by":"crossref","first-page":"61860","DOI":"10.18632\/oncotarget.11452","article-title":"Low-dose actinomycin-D treatment re-establishes the tumour suppressive function of P53 in RELA-positive ependymoma","volume":"7","author":"Tzaridis","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejso.2020.06.040_bib29","article-title":"Systemic treatments for metastatic cutaneous melanoma","author":"Pasquali","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejso.2020.06.040_bib30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1158\/2326-6066.CIR-17-0356","article-title":"Robust antitumor responses result from local chemotherapy and CTLA-4 blockade","volume":"6","author":"Ariyan","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ejso.2020.06.040_bib31","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1200\/JCO.2010.32.1224","article-title":"Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma","volume":"29","author":"Beasley","year":"2011","journal-title":"J\u00a0Clin Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320305655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320305655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:35:13Z","timestamp":1760060113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798320305655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0748798320305655"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2020.06.040","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors predicting toxicity and response following isolated limb infusion for melanoma: An international multi-centre study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2020.06.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}